234 related articles for article (PubMed ID: 31022584)
1. Discovery of novel acylhydrazone neuraminidase inhibitors.
Zhao ZX; Cheng LP; Li M; Pang W; Wu FH
Eur J Med Chem; 2019 Jul; 173():305-313. PubMed ID: 31022584
[TBL] [Abstract][Full Text] [Related]
2. Discovery of (E)-1-amino-4-phenylbut-3-en-2-ol derivatives as novel neuraminidase inhibitors.
Lu C; Yin Y; Meng F; Dun Y; Pei K; Wang C; Xu X; Wu F
Bioorg Med Chem Lett; 2018 Jun; 28(11):2003-2007. PubMed ID: 29748050
[TBL] [Abstract][Full Text] [Related]
3. Novel N-Substituted oseltamivir derivatives as potent influenza neuraminidase inhibitors: Design, synthesis, biological evaluation, ADME prediction and molecular docking studies.
Ye J; Yang X; Xu M; Chan PK; Ma C
Eur J Med Chem; 2019 Nov; 182():111635. PubMed ID: 31493744
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of novel 1, 3, 4-oxadiazole derivatives as potent neuraminidase inhibitors.
Yu W; Ping Cheng L; Pang W; Ling Guo L
Bioorg Med Chem; 2022 Mar; 57():116647. PubMed ID: 35121400
[TBL] [Abstract][Full Text] [Related]
5. Discovery of berberine based derivatives as anti-influenza agent through blocking of neuraminidase.
Enkhtaivan G; Muthuraman P; Kim DH; Mistry B
Bioorg Med Chem; 2017 Oct; 25(20):5185-5193. PubMed ID: 28958846
[TBL] [Abstract][Full Text] [Related]
6. Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavity.
Jia R; Zhang J; Bertagnin C; Cherukupalli S; Ai W; Ding X; Li Z; Zhang J; Ju H; Ma X; Loregian A; Huang B; Zhan P; Liu X
Eur J Med Chem; 2021 Feb; 212():113097. PubMed ID: 33385836
[TBL] [Abstract][Full Text] [Related]
7. Discovery of C-1 modified oseltamivir derivatives as potent influenza neuraminidase inhibitors.
Ju H; Zhang J; Sun Z; Huang Z; Qi W; Huang B; Zhan P; Liu X
Eur J Med Chem; 2018 Feb; 146():220-231. PubMed ID: 29407952
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel thiophene derivatives as potent neuraminidase inhibitors.
Zhong ZJ; Hu XT; Cheng LP; Zhang XY; Zhang Q; Zhang J
Eur J Med Chem; 2021 Dec; 225():113762. PubMed ID: 34411893
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel "Dual-site" binding oseltamivir derivatives as potent influenza virus neuraminidase inhibitors.
Ai W; Zhang J; Zalloum WA; Jia R; Cherukupalli S; Ding X; Sun Z; Sun L; Jiang X; Ma X; Li Z; Wang D; Huang B; Zhan P; Liu X
Eur J Med Chem; 2020 Apr; 191():112147. PubMed ID: 32092589
[TBL] [Abstract][Full Text] [Related]
10. Divalent oseltamivir analogues as potent influenza neuraminidase inhibitors.
Yan ZL; Liu AY; Wei XX; Zhang Z; Qin L; Yu Q; Yu P; Lu K; Yang Y
Carbohydr Res; 2019 May; 477():32-38. PubMed ID: 30954773
[TBL] [Abstract][Full Text] [Related]
11. Discovery andsynthesis of novel benzoylhydrazone neuraminidase inhibitors.
Fu SK; Cheng LP
Bioorg Med Chem Lett; 2024 Jun; 105():129743. PubMed ID: 38608962
[TBL] [Abstract][Full Text] [Related]
12. Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.
Xie Y; Xu D; Huang B; Ma X; Qi W; Shi F; Liu X; Zhang Y; Xu W
J Med Chem; 2014 Oct; 57(20):8445-58. PubMed ID: 25255388
[TBL] [Abstract][Full Text] [Related]
13. Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors.
Li Z; Meng Y; Xu S; Shen W; Meng Z; Wang Z; Ding G; Huang W; Xiao W; Xu J
Bioorg Med Chem; 2017 May; 25(10):2772-2781. PubMed ID: 28385598
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors.
Xiao M; Xu L; Lin D; Lian W; Cui M; Zhang M; Yan X; Li S; Zhao J; Ye J; Liu A; Hu A
Eur J Med Chem; 2021 Mar; 213():113161. PubMed ID: 33540229
[TBL] [Abstract][Full Text] [Related]
15. Discovery of hydrazide-containing oseltamivir analogues as potent inhibitors of influenza A neuraminidase.
Zhao H; Jiang S; Ye Z; Zhu H; Hu B; Meng P; Hu Y; Zhang H; Wang K; Wang J; Tian Y
Eur J Med Chem; 2021 Oct; 221():113567. PubMed ID: 34082224
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel 1,2,3-triazole oseltamivir derivatives as potent influenza neuraminidase inhibitors targeting the 430-cavity.
Ju H; Xiu S; Ding X; Shang M; Jia R; Huang B; Zhan P; Liu X
Eur J Med Chem; 2020 Feb; 187():111940. PubMed ID: 31835169
[TBL] [Abstract][Full Text] [Related]
17. A phospha-oseltamivir-biotin conjugate as a strong and selective adhesive for the influenza virus.
Streicher H; Martin SR; Coombs PJ; McCauley J; Neill-Hall D; Stanley M
Bioorg Med Chem Lett; 2014 Apr; 24(7):1805-7. PubMed ID: 24594352
[TBL] [Abstract][Full Text] [Related]
18. Oseltamivir hydroxamate and acyl sulfonamide derivatives as influenza neuraminidase inhibitors.
Hong BT; Chen CL; Fang JM; Tsai KC; Wang SY; Huang WI; Cheng YE; Wong CH
Bioorg Med Chem; 2014 Dec; 22(23):6647-6654. PubMed ID: 25456388
[TBL] [Abstract][Full Text] [Related]
19. Recent progress and challenges in the discovery of new neuraminidase inhibitors.
Chamni S; De-Eknamkul W
Expert Opin Ther Pat; 2013 Apr; 23(4):409-23. PubMed ID: 23369206
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of dihydrofurocoumarin derivatives as potent neuraminidase inhibitors.
Zhong ZJ; Cheng LP; Pang W; Zheng XS; Fu SK
Bioorg Med Chem Lett; 2021 Apr; 37():127839. PubMed ID: 33556571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
